Tiotropium bromide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tiotropium bromide" in English language version.

refsWebsite

Global rank English rank

16web.archive.org

1^st place

13nih.gov

4^th place

9doi.org

2^nd place

5medicines.org.uk

3,823^rd place

2,387^th place

3tga.gov.au

3,984^th place

2,622^nd place

2drugs.com

399^th place

333^rd place

2handle.net

102^nd place

76^th place

2clincalc.com

3,912^th place

2,496^th place

1books.google.com

3^rd place

1goldcopd.org

low place

1ginasthma.org

low place

1fda.gov

447^th place

338^th place

1tg.org.au

low place

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 447. ISBN 9783527607495.

clincalc.com

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Tiotropium Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.

doi.org

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M (October 2008). "A 4-year trial of tiotropium in chronic obstructive pulmonary disease". The New England Journal of Medicine. 359 (15): 1543–1554. doi:10.1056/nejmoa0805800. hdl:2437/111564. PMID 18836213.
Rodrigo GJ, Castro-Rodríguez JA (February 2015). "What is the role of tiotropium in asthma?: a systematic review with meta-analysis". Chest. 147 (2): 388–396. doi:10.1378/chest.14-1698. PMID 25322075.
Kesten S, Jara M, Wentworth C, Lanes S (December 2006). "Pooled clinical trial analysis of tiotropium safety". Chest. 130 (6): 1695–1703. doi:10.1378/chest.130.6.1695. PMID 17166984.
Singh S, Loke YK, Furberg CD (September 2008). "Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis". JAMA. 300 (12): 1439–1450. doi:10.1001/jama.300.12.1439. PMID 18812535.
Singh S, Loke YK, Enright PL, Furberg CD (June 2011). "Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials". BMJ. 342: d3215. doi:10.1136/bmj.d3215. PMC 3114950. PMID 21672999.
"Tiotropium bromide". Australian Prescriber. 26 (1). January 2003. doi:10.18773/austprescr.2003.015. Retrieved 11 July 2024.
Kato M, Komamura K, Kitakaze M (December 2006). "Tiotropium, a novel muscarinic M3 receptor antagonist, improved symptoms of chronic obstructive pulmonary disease complicated by chronic heart failure". Circulation Journal. 70 (12): 1658–1660. doi:10.1253/circj.70.1658. PMID 17127817.
Dahl R, Kaplan A (October 2016). "A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?". BMC Pulmonary Medicine. 16 (1): 135. doi:10.1186/s12890-016-0291-4. PMC 5057252. PMID 27724909.
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, et al. (October 2013). "Tiotropium Respimat inhaler and the risk of death in COPD". The New England Journal of Medicine. 369 (16): 1491–1501. doi:10.1056/NEJMoa1303342. PMID 23992515.

drugs.com

"Tiotropium Use During Pregnancy". Drugs.com. Archived from the original on 31 January 2019. Retrieved 31 January 2019.
"Tiotropium Bromide Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 14 October 2018. Retrieved 31 January 2019.

fda.gov

"Follow-Up to the October 2008 Updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler)". U.S. Food and Drug Administration (FDA). 14 January 2010. Archived from the original on 2 November 2017. Retrieved 20 December 2019.

ginasthma.org

Global Strategy for Asthma Management and Prevention (2020 update) (PDF). GOLD. 2020. Archived (PDF) from the original on 19 May 2020. Retrieved 10 May 2020.

goldcopd.org

Pocket Guide to COPD Diagnosis, Management and Prevention [Internet] Fontana, WI The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 [Cited 12 April 2020] Available from: https://goldcopd.org/wp-content/uploads/2020/03/GOLD-2020-POCKET-GUIDE-ver1.0_FINAL-WMV.pdf Archived 12 July 2020 at the Wayback Machine

handle.net

hdl.handle.net

World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M (October 2008). "A 4-year trial of tiotropium in chronic obstructive pulmonary disease". The New England Journal of Medicine. 359 (15): 1543–1554. doi:10.1056/nejmoa0805800. hdl:2437/111564. PMID 18836213.

medicines.org.uk

"Spiriva 18 microgram inhalation powder, hard capsule - Summary of Product Characteristics (SmPC)". (emc). 15 January 2019. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Spiriva Respimat 2.5 microgram, inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 14 January 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Tiogiva 18 microgram, inhalation powder, hard capsule - Summary of Product Characteristics (SmPC)". (emc). 2 June 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 14 January 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Yanimo Respimat 2.5 microgram/2.5 microgram, inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 14 January 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M (October 2008). "A 4-year trial of tiotropium in chronic obstructive pulmonary disease". The New England Journal of Medicine. 359 (15): 1543–1554. doi:10.1056/nejmoa0805800. hdl:2437/111564. PMID 18836213.
Rodrigo GJ, Castro-Rodríguez JA (February 2015). "What is the role of tiotropium in asthma?: a systematic review with meta-analysis". Chest. 147 (2): 388–396. doi:10.1378/chest.14-1698. PMID 25322075.
Kesten S, Jara M, Wentworth C, Lanes S (December 2006). "Pooled clinical trial analysis of tiotropium safety". Chest. 130 (6): 1695–1703. doi:10.1378/chest.130.6.1695. PMID 17166984.
Singh S, Loke YK, Furberg CD (September 2008). "Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis". JAMA. 300 (12): 1439–1450. doi:10.1001/jama.300.12.1439. PMID 18812535.
Singh S, Loke YK, Enright PL, Furberg CD (June 2011). "Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials". BMJ. 342: d3215. doi:10.1136/bmj.d3215. PMC 3114950. PMID 21672999.
Kato M, Komamura K, Kitakaze M (December 2006). "Tiotropium, a novel muscarinic M3 receptor antagonist, improved symptoms of chronic obstructive pulmonary disease complicated by chronic heart failure". Circulation Journal. 70 (12): 1658–1660. doi:10.1253/circj.70.1658. PMID 17127817.
Dahl R, Kaplan A (October 2016). "A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?". BMC Pulmonary Medicine. 16 (1): 135. doi:10.1186/s12890-016-0291-4. PMC 5057252. PMID 27724909.
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, et al. (October 2013). "Tiotropium Respimat inhaler and the risk of death in COPD". The New England Journal of Medicine. 369 (16): 1491–1501. doi:10.1056/NEJMoa1303342. PMID 23992515.

dailymed.nlm.nih.gov

"Spiriva Handihaler- tiotropium bromide capsule". DailyMed. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Spiriva Respimat- tiotropium bromide inhalation spray spray, metered". DailyMed. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Stiolto Respimat- tiotropium bromide and olodaterol spray, metered". DailyMed. Archived from the original on 1 October 2021. Retrieved 30 September 2021.

ncbi.nlm.nih.gov

Singh S, Loke YK, Enright PL, Furberg CD (June 2011). "Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials". BMJ. 342: d3215. doi:10.1136/bmj.d3215. PMC 3114950. PMID 21672999.
Dahl R, Kaplan A (October 2016). "A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?". BMC Pulmonary Medicine. 16 (1): 135. doi:10.1186/s12890-016-0291-4. PMC 5057252. PMID 27724909.

tg.org.au

australianprescriber.tg.org.au

"Tiotropium bromide". Australian Prescriber. 26 (1). January 2003. doi:10.18773/austprescr.2003.015. Retrieved 11 July 2024.

tga.gov.au

"AusPAR: Tiotropium bromide". Therapeutic Goods Administration (TGA). 29 November 2016. Archived from the original on 1 October 2021. Retrieved 30 September 2021.

ebs.tga.gov.au

https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=E07D6674E971FA91CA258752004228AF&agid=(PrintDetailsPublic)&actionid=1 ^{[dead link‍]}

search.tga.gov.au

"Tiotropium bromide". Therapeutic Goods Administration (TGA). Archived from the original on 1 October 2021. Retrieved 30 September 2021.

web.archive.org

"Tiotropium Use During Pregnancy". Drugs.com. Archived from the original on 31 January 2019. Retrieved 31 January 2019.
"AusPAR: Tiotropium bromide". Therapeutic Goods Administration (TGA). 29 November 2016. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Tiotropium bromide". Therapeutic Goods Administration (TGA). Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Spiriva 18 microgram inhalation powder, hard capsule - Summary of Product Characteristics (SmPC)". (emc). 15 January 2019. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Spiriva Respimat 2.5 microgram, inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 14 January 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Tiogiva 18 microgram, inhalation powder, hard capsule - Summary of Product Characteristics (SmPC)". (emc). 2 June 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Spiriva Handihaler- tiotropium bromide capsule". DailyMed. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Spiriva Respimat- tiotropium bromide inhalation spray spray, metered". DailyMed. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Tiotropium Bromide Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 14 October 2018. Retrieved 31 January 2019.
"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
Pocket Guide to COPD Diagnosis, Management and Prevention [Internet] Fontana, WI The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 [Cited 12 April 2020] Available from: https://goldcopd.org/wp-content/uploads/2020/03/GOLD-2020-POCKET-GUIDE-ver1.0_FINAL-WMV.pdf Archived 12 July 2020 at the Wayback Machine
Global Strategy for Asthma Management and Prevention (2020 update) (PDF). GOLD. 2020. Archived (PDF) from the original on 19 May 2020. Retrieved 10 May 2020.
"Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 14 January 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Yanimo Respimat 2.5 microgram/2.5 microgram, inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 14 January 2021. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Stiolto Respimat- tiotropium bromide and olodaterol spray, metered". DailyMed. Archived from the original on 1 October 2021. Retrieved 30 September 2021.
"Follow-Up to the October 2008 Updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler)". U.S. Food and Drug Administration (FDA). 14 January 2010. Archived from the original on 2 November 2017. Retrieved 20 December 2019.